sofidexFor patientsAre you a clinician? Clinical site
Ask Sofi
Listen
Patient SupportEmergencies & Reporting
Log inSign up

Meds & supplements  ›  Doxercalciferol

Medicine · Vitamin D2 Analog

Doxercalciferol

Doxercalciferol capsules are indicated for the treatment of secondary hyperparathyroidism in adult patients with Stage 3 or Stage 4 chronic kidney disease (CKD) and adult patients with CKD on dialysis.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
Doxercalciferol capsules are indicated for the treatment of secondary hyperparathyroidism in adult patients with Stage 3 or Stage 4 chronic kidney disease (CKD) and adult patients with CKD on dialysis.
Do not take if
  • Hypercalcemia
  • Vitamin D toxicity
  • Known hypersensitivity to doxercalciferol or any of the inactive ingredients of doxercalciferol capsules; serious hypersensitivity reactions including anaphylaxis and angioedema have been reported.

What it is used for

  • Doxercalciferol capsules are indicated for the treatment of secondary hyperparathyroidism in adult patients with Stage 3 or Stage 4 chronic kidney disease (CKD) and adult patients with CKD on dialysis.

Side effects, and when to stop

The following adverse reactions are discussed in greater detail in another section of the label:

  • Hypercalcemia
  • Serious Hypersensitivity Reactions
  • Adynamic Bone Disease

Who should not take it

Doxercalciferol is contraindicated in patients with:

  • Hypercalcemia
  • Vitamin D toxicity
  • Known hypersensitivity to doxercalciferol or any of the inactive ingredients of doxercalciferol capsules; serious hypersensitivity reactions including anaphylaxis and angioedema have been reported.

Other medicines and interactions

Tables 3 and 4 include clinically significant drug interactions with doxercalciferol.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Doxercalciferol; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/doxercalciferol

APA 7th

sofidex. (2026, August 2). Doxercalciferol. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/doxercalciferol

AMA 11th

Doxercalciferol. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/doxercalciferol

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.